share_log

Navidea Biopharmaceuticals | 10-K: FY2019 Annual Report

SEC ·  Mar 18, 2020 16:29
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more